WCN26-5400 Comparative Effectiveness of Bisphosphonates and Denosumab for Fracture Prevention in Chronic Kidney Disease: A Real-World New-User Cohort Study

Read full text Summarise with VIRAT
Authors: Arisa Kobayashi, Keita Hirano, Tatsuyoshi Ikenoue, Takashi Yokoo, Shingo Fukuma
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Patients with chronic kidney disease (CKD) are at markedly increased risk of fragility fractures, which impair activities of daily living and contribute to excess morbidity and mortality. Although anti-osteoporosis therapy is essential in this high-risk population, evidence for its fracture-preventive efficacy in CKD remains limited and is largely derived from small studies. We aimed to compare the real-world effectiveness and safety of bisphosphonates and denosumab for fracture prevention in patients with CKD.

Fields of Study & Subjects

Bone health and osteoporosis research Bone health and treatments Parathyroid Disorders and Treatments

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104821–104821
Publication date
25 March 2026
Language
EN